{"id":"e018aaf0-1d79-4271-a024-460da8239c51","kind":"news","code":"e018aaf0-1d79-4271-a024-460da8239c51","name":"Biyang Pharmaceutical raises RMB 200 million in Series A financing","nameBasis":"translated-title","summary":"On 2026-7-17, according to Xiniu Data, Biyang Pharmaceutical completed Series A financing, raising RMB 200 million.","description":"","country":null,"category":null,"originalName":"必扬医药完成A轮融资，金额2亿人民币","eventDate":"2026-07-17T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-18T16:54:19.718Z","englishUpdatedAt":"2026-10-21T16:31:29.498Z","reviewedAt":"2026-10-21T16:31:29.498Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"9a15ac5a71bc716e9be32926172b340ed9cdb93643061f4a3fe164e6f2271390","companyId":"4c78222d-f089-4568-84e9-6705393238d6","foundedYear":null,"logoUrl":null,"transactionConsiderationUsd":null,"considerationLabel":null,"amountEstimateUsd":28571428,"fundingEstimateUsd":28571428,"fundingEstimateLabel":"RMB 200M","originalText":"2026年7月17日，据烯牛数据报道，必扬医药完成A轮融资，金额2亿人民币。该公司为AI驱动的创新生物医药研发商。","sources":[],"related":[{"id":"4c78222d-f089-4568-84e9-6705393238d6","kind":"companies","code":"UB-C10517","name":"Biyang Pharmaceutical","nameBasis":"transliterated","summary":"AI-powered innovative biopharmaceutical developer.","description":"AI-powered innovative biopharmaceutical developer.","country":"China","category":null,"originalName":"必扬医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T00:00:00.000Z","englishUpdatedAt":"2026-10-22T00:59:11.418Z","reviewedAt":"2026-10-22T00:59:11.418Z","snapshotAt":"2026-10-22T00:45:51.500Z","sourceHash":"c80ba132b997d5818221b22736c0cb65fe24a98ce777cc80c49c8ffb199592db","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C10517"},{"id":"d4eb3b96-139f-4b1f-a783-fece1f2819e1","kind":"institutions","code":"UB-I8542","name":"Chengdu Junrongkang Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Chengdu Junrongkang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Chengdu Junrongkang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"成都君蓉康创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.313Z","englishUpdatedAt":"2026-10-23T01:33:25.961Z","reviewedAt":"2026-10-23T01:33:25.961Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"22452514a8dca80614791e076f3e488ca2fd19b9e5223d27d90bae1791c53b63","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/chengdu-junrongkang-venture-capital-partnership-limited-partnership"},{"id":"0c0b4656-01cb-4f7f-a81b-d54d96d17f76","kind":"institutions","code":"UB-I8416","name":"Foshanshigangyuelieyaoshisanguquan Investment Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Foshanshigangyuelieyaoshisanguquan Investment Partnership (Limited Partnership), a private equity investment firm focused on healthcare.","description":"Foshanshigangyuelieyaoshisanguquan Investment Partnership (Limited Partnership), a private equity investment firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"佛山市港粤猎药十三股权投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.408Z","englishUpdatedAt":"2026-10-23T01:33:15.264Z","reviewedAt":"2026-10-23T01:33:15.264Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"66d7878b9051f58fa7b79f8e5a5b8563b739b49580d301bf633ee79c3dda1fe2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foshanshigangyuelieyaoshisanguquan-investment-partnership-limited-partnership"},{"id":"398185af-8495-40e5-835c-3a8f8b3f7279","kind":"institutions","code":"UB-I8468","name":"Hainan Shengkangzhe Venture Capital Co., Ltd.","nameBasis":"transliterated","summary":"Hainan Shengkangzhe Venture Capital Co., Ltd., an early-stage venture capital firm focused on healthcare.","description":"Hainan Shengkangzhe Venture Capital Co., Ltd., an early-stage venture capital firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"海南省康哲创业投资有限公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.329Z","englishUpdatedAt":"2026-10-23T01:33:15.640Z","reviewedAt":"2026-10-23T01:33:15.640Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"3df4d4633906b19d202ccb824df31e090588f1b8f7a2f2aff9b1569da8c40b70","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hainan-shengkangzhe-venture-capital-co-ltd"},{"id":"d980be71-12f9-46d9-829e-b71c2f03ea92","kind":"institutions","code":"UB-I8489","name":"Hangzhou Yuanchangguquan Investment Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Hangzhou Yuanchangguquan Investment Partnership (Limited Partnership), a private equity investment firm focused on healthcare.","description":"Hangzhou Yuanchangguquan Investment Partnership (Limited Partnership), a private equity investment firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"杭州元畅股权投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.337Z","englishUpdatedAt":"2026-10-23T01:33:26.026Z","reviewedAt":"2026-10-23T01:33:26.026Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"d54021c554808e38dc51d76cc327121a785a5cc5a3e732e0d38e214a2bfe0517","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hangzhou-yuanchangguquan-investment-partnership-limited-partnership"},{"id":"dca4f14c-e0ca-42ca-8bcf-462ad04b1f8e","kind":"institutions","code":"UB-I8531","name":"Shanghai International Group Chuangling Phase One Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shanghai International Group Chuangling Phase One Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Shanghai International Group Chuangling Phase One Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"上海国际集团创领一期创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.345Z","englishUpdatedAt":"2026-10-23T01:33:26.044Z","reviewedAt":"2026-10-23T01:33:26.044Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"08e9cc49a8be8dcbd9b8291af249ba7aabd677c1dfa2f4f1be3eedc697cb519d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shanghai-international-group-chuangling-phase-one-venture-capital-partnership-limited-partnership"},{"id":"a7dea9d9-bd6b-421b-99fd-d852d53b7fcc","kind":"institutions","code":"UB-I8567","name":"Shanghai Shangshi Phase Two Biotechnology Pharmaceutical Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shanghai Shangshi Phase Two Biotechnology Pharmaceutical Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Shanghai Shangshi Phase Two Biotechnology Pharmaceutical Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"上海上实二期生物医药创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.322Z","englishUpdatedAt":"2026-10-23T01:33:25.627Z","reviewedAt":"2026-10-23T01:33:25.627Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"61bd43c477ae829e7b4f5b0447aa2e826d1239955d35576398ad52f15ebc9157","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shanghai-shangshi-phase-two-biotechnology-pharmaceutical-venture-capital-partnership-limited-partnership"},{"id":"82df41a7-67f0-4269-9c70-9c37651b95b2","kind":"institutions","code":"UB-I8442","name":"Shenzhen City Yuanshengtianshi Phase Two Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shenzhen City Yuanshengtianshi Phase Two Venture Capital Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Shenzhen City Yuanshengtianshi Phase Two Venture Capital Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":"Mainland China","category":null,"originalName":"深圳市元生天使二期创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-22T19:00:21.417Z","englishUpdatedAt":"2026-10-23T01:33:17.902Z","reviewedAt":"2026-10-23T01:33:17.902Z","snapshotAt":"2026-10-23T01:25:29.879Z","sourceHash":"2c15c66b1c3be85771552f681c3099fb4044bf7a8c03ffcd6adb95d77c97a987","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shenzhen-city-yuanshengtianshi-phase-two-venture-capital-partnership-limited-partnership"},{"id":"97bf1920-c575-4c28-8ba9-5d34eba27169","kind":"institutions","code":"UB-I8392","name":"Yuanjin Venture Capital","nameBasis":"transliterated","summary":"Yuanjin Venture Capital, an early-stage venture capital firm focused on healthcare.","description":"Yuanjin Venture Capital, an early-stage venture capital firm focused on healthcare.","country":"Mainland China","category":null,"originalName":"源津创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T12:00:20.017Z","englishUpdatedAt":"2026-10-21T16:19:07.426Z","reviewedAt":"2026-10-21T16:19:07.426Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3cf94ed69d881886113ab68c8c0091a200c2e97c852fa1040f097e8929b4ea63","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/yuanjin-venture-capital"}],"path":"/news/e018aaf0-1d79-4271-a024-460da8239c51","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Biyang Pharmaceutical","path":"/companies/UB-C10517"}},"canonical":"https://uniquebase.ai/news/e018aaf0-1d79-4271-a024-460da8239c51"}